27 articles for RK Guy
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents.
Duke University School of Medicine
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).
St. Jude Children'S Research Hospital
Synthesis and evaluation of methylsulfonylnitrobenzamides (MSNBAs) as inhibitors of the thyroid hormone receptor-coactivator interaction.
St. Jude Children'S Research Hospital
Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.
St. Jude Children'S Research Hospital
Lead optimization of antimalarial propafenone analogues.
St. Jude Children'S Research Hospital
Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.
University of Wisconsin-Milwaukee
Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPTs) as thyroid hormone receptor-coactivator interaction inhibitors.
Institut Pasteur Korea
Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
University of California
A surface on the androgen receptor that allosterically regulates coactivator binding.
University of California
Investigation of the PDZ domain ligand binding site using chemically modified peptides.
University of California
Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening.
University of British Columbia
Optimization of propafenone analogues as antimalarial leads.
St. Jude Children'S Research Hospital
Podophyllotoxin analogues active versus Trypanosoma brucei.
Vanderbilt University School of Medicine
Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.
St. Jude Children'S Hospital
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain.
University of California San Francisco
Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M.
University of Kentucky
Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.
St. Jude Children'S Research Hospital
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.
St. Jude Children'S Research Hospital
MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF
Gluetacs Therapeutics (Shanghai) Co.
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
Achillion Pharmaceuticals